MetaCap

Cerenome (CNSY) vs WORK Medical Technology Group LTD (WOK)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cerenome is the larger company by market cap ($6.2 million vs $4.9 million), about 1.3 times the size. WORK Medical Technology Group LTD converts more of its revenue into profit, with a net margin of -10.9% versus -429.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CNSY-61.46%WOK-29.31%
+22%-24%-69%
Oct 7, 20261 yearNov 20, 2026
CNSY-67.35%WOK-28.39%
+3%-34%-71%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CNSY versus WOK key metrics
MetricCNSYWOK
Share price$0.6301$1.10
Market cap$6.16M$4.90M
1-day change-10.29%-5.13%
YTD return-95.06%—
1-year return-95.24%—
5-year return-99.89%—
EPS (TTM)$-3.50$-51,993.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$5.21M$9.85M
Revenue growth (YoY)-10.49%-14.41%
Net income (latest FY)$-22.39M$-1.07M
Gross margin—23.81%
Operating margin-293.46%—
Net margin-429.43%-10.89%
52-week high$19.00$83,600.00
52-week low$0.43$0.91
Distance from 52-week high-96.68%-100.00%
Analyst consensusstrong_buy—
Avg. price target upside+4304.06%—
Average volume804.18K71.02K
Shares outstanding9.78M4.42M
Employees28238
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • WORK Medical Technology Group LTD is more profitable, keeping -10.9 cents of every revenue dollar as net income versus -429.4 cents for Cerenome.

About Cerenome

CNSY stock →

Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.

Health Care · Medical/Dental Instruments · 28 employees

About WORK Medical Technology Group LTD

WOK stock →

WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators.

Health Care · Medical/Dental Instruments · 238 employees

CNSY vs WOK FAQ

Which is bigger, Cerenome or WORK Medical Technology Group LTD?

Cerenome (CNSY) is larger, with a market capitalization of $6.16M compared with $4.90M for WORK Medical Technology Group LTD (WOK).

Are Cerenome and WORK Medical Technology Group LTD in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons